SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine

Clinical trial NCT02716948 · COMPLETED

Trial details

NCT number: NCT02716948
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Brain Metastatic Malignant Neoplasm in the Spine Stage IV Skin Melanoma

Start date: 2016-06-23
Primary completion: 2021-08-27
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.